Dogwood Therapeutics, Inc. (DWTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.43M
Last updated: Nov 17, 2026 at 11:01 AM ET
Dogwood Therapeutics, Inc. (DWTX) Competitors
The companies most similar to Dogwood Therapeutics are Gain Therapeutics (GANX), OS Therapies (OSTX) and Plus Therapeutics (PSTV). By market cap, Dogwood Therapeutics ranks 7th of the 13 companies on this page; Tenax Therapeutics (TENX) is the largest at $73.77M.
Peer Comparison
DWTX's revenue growth of 0.0% is above the peer median of -1.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics (DWTX) | $42.43M | N/A | 361.8x | 0.0% | N/A | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Werewolf Therapeutics Inc (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Verrica Pharmaceuticals Inc (VRCA) | $61.16M | N/A | 3.0x | -189.2% | -496.2% | -51.8% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Edesa Biotech Inc (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| NanoViricides Inc (NNVC) | $31.41M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $40.36M | 4.1x | 2.3x | 0.0% | -333.4% | -1.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Dogwood Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Werewolf Therapeutics Inc (HOWL) | Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. | HOWL competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Verrica Pharmaceuticals Inc (VRCA) | Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. | VRCA competitors |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| Edesa Biotech Inc (EDSA) | Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development... | EDSA competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| NanoViricides Inc (NNVC) | NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. | NNVC competitors |
Frequently Asked Questions About DWTX
Who are Dogwood Therapeutics' main competitors?
The companies most similar to Dogwood Therapeutics include Gain Therapeutics (GANX), OS Therapies (OSTX), Plus Therapeutics (PSTV), Telomir Pharmaceuticals, Inc. Common Stock (TELO) and Werewolf Therapeutics (HOWL), listed from the closest match.
Who is Dogwood Therapeutics' biggest competitor?
Tenax Therapeutics (TENX) is the largest of the similar companies at $73.77M; Gain Therapeutics (GANX) is the closest match by business profile, size, sector and industry.
How does DWTX stock compare with its competitors?
DWTX's P/S is 361.8x against a peer median of 2.3x; its net margin is 0.0% against a peer median of 0.0%.
Which of Dogwood Therapeutics' competitors pays a higher dividend?
Dogwood Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Dogwood Therapeutics bigger than its competitors?
No. Dogwood Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Tenax Therapeutics (TENX) at $73.77M.
DWTX pages: Overview, Earnings, Forecast, Financials, Competitors